NCT05312710: Safety and Efficacy of APG-157 in Head and Neck Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 24 planned
- Started
- 22 Apr 2022
- Primary completion
- Dec 2026
- Arms
- APG-157
- Results
- None posted
- 5 Apr 2022: Trial registered
- 22 Apr 2022: Trial started